Ibane Abasolo Selected Research

nucleolin binding peptide

2/2020

Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ibane Abasolo Research Topics

Disease

31	Neoplasms (Cancer) 12/2021 - 04/2002
7	Breast Neoplasms (Breast Cancer) 05/2021 - 11/2018
6	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2003
6	Fabry Disease (Fabry's Disease) 07/2021 - 04/2016
4	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 12/2011
3	Carcinogenesis 10/2021 - 11/2018
3	Neoplasm Metastasis (Metastasis) 10/2021 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 12/2021 - 01/2017
2	Circulating Neoplastic Cells 10/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 09/2003 - 04/2002
1	Hypersensitivity (Allergy) 01/2022
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 07/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 05/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 04/2020
1	Triple Negative Breast Neoplasms 02/2020
1	Chronic Disease (Chronic Diseases) 09/2019
1	Lymphatic Metastasis 01/2017
1	Brain Ischemia (Cerebral Ischemia) 05/2009
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2009
1	Infarction (Infarctions) 05/2009
1	Brain Infarction 05/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2009
1	Ischemia 05/2009

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 01/2022 - 12/2011
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2014
6	AdrenomedullinIBA 01/2006 - 04/2002
5	Small Interfering RNA (siRNA)IBA 05/2021 - 12/2012
5	Peptides (Polypeptides)IBA 02/2020 - 04/2002
4	EnzymesIBA 07/2021 - 04/2016
4	GalactosidasesIBA 07/2021 - 04/2016
3	MicellesIBA 10/2021 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 10/2014
3	Biological ProductsIBA 05/2021 - 12/2011
3	LigandsIBA 02/2020 - 10/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2021
2	HydrogelsIBA 12/2021 - 09/2021
2	Cytotoxins (Cytolysins)IBA 12/2016 - 05/2005
2	AndrogensIBA 09/2003 - 04/2002
1	polyacetalIBA 01/2022
1	poly(ethylene glycol)diacrylateIBA 12/2021
1	Niclosamide FDA Link 10/2021
1	NanodiamondsIBA 05/2021
1	Hyaluronic Acid (Hyaluronan)IBA 05/2021
1	Naproxen (Naprosyn)FDA LinkGeneric 05/2021
1	HydrolasesIBA 02/2021
1	UCON 50-HB-5100 (F127)IBA 01/2021
1	Poloxamer (Poloxamer 407)IBA 01/2021
1	citral (neral)IBA 01/2021
1	AntioxidantsIBA 04/2020
1	nucleolin binding peptideIBA 02/2020
1	NucleolinIBA 02/2020
1	Drug CarriersIBA 02/2020
1	Cell Surface ReceptorsIBA 02/2020
1	PolymersIBA 01/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 07/2019
1	4- (4- chlorobenzyl)- 1- (7H- pyrrolo(2,3- d)pyrimidin- 4- yl)piperidin- 4- amineIBA 07/2019
1	Aldehyde DehydrogenaseIBA 07/2019
1	AntibodiesIBA 12/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2018
1	ProteomeIBA 12/2018
1	Polyurethanes (Polyurethane)IBA 01/2018
1	polyureaIBA 01/2018
1	EphA1 Receptor (Eph Receptor)IBA 01/2017
1	AgarIBA 01/2017
1	ChitosanIBA 10/2016
1	PolyelectrolytesIBA 10/2016
1	GlycosphingolipidsIBA 04/2016
1	cyclic arginine-glycine-aspartic acid peptideIBA 10/2015
1	DisulfidesIBA 10/2015
1	IntegrinsIBA 10/2015
1	Glutathione (Reduced Glutathione)IBA 10/2015
1	selenoureaIBA 06/2015
1	Liposomes (Liposome)IBA 09/2013
1	CamptothecinIBA 12/2011
1	Silicon Dioxide (Silica)FDA LinkGeneric 12/2011
1	CY5.5 cyanine dyeIBA 12/2011
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2011
1	Messenger RNA (mRNA)IBA 05/2009
1	Glucose (Dextrose)FDA LinkGeneric 05/2009
1	Etoposide (VP 16)FDA LinkGeneric 01/2006
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2006
1	Metallothionein 3IBA 01/2006
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 05/2005
1	IL13-PE38IBA 05/2005
1	peptidylglycine monooxygenaseIBA 09/2003
1	Pathogen-Associated Molecular Pattern MoleculesIBA 04/2002

Therapy/Procedure

11	Therapeutics 01/2022 - 09/2003
2	Intravenous Injections 05/2021 - 05/2009
2	Drug Therapy (Chemotherapy) 05/2021 - 01/2021
1	Treatment Delay 12/2011